Preliminary assessment of a Haemophilus parasuis bacterin for use in specific pathogen free swine
- PMID: 2531627
- PMCID: PMC1255564
Preliminary assessment of a Haemophilus parasuis bacterin for use in specific pathogen free swine
Abstract
A whole cell formalin killed trivalent Haemophilus parasuis bacterin was tested for efficacy in four week old, weaned specific pathogen free pigs challenged under laboratory conditions. The vaccine contained three field strains of H. parasuis selected from confirmed cases of Glasser's disease. Two different formulations were evaluated in separate trials. In trial 1, ten pigs received 5 mL of bacterin subcutaneously in the neck, followed by a second 5 mL dose two weeks later. Another ten pigs served as nonvaccinated controls. One week after the second dose, all pigs were subjected to an aerosol challenge containing the strains of H. parasuis present in the vaccine. In trial 2, a broth rather than a saline based vaccine was prepared, and tested as in trial 1. In both trials, the vaccinated pigs remained healthy postchallenge, while eight of nine (Trial 1) and eight of ten (Trial 2) nonvaccinated pigs succumbed to Glasser's disease.
Similar articles
-
The effect of a homologous bacterin given to sows prefarrowing on the development of Glässer's disease in postweaning pigs after i.v. challenge with Haemophilus parasuis serotype 5.Dtsch Tierarztl Wochenschr. 2002 Jun;109(6):271-6. Dtsch Tierarztl Wochenschr. 2002. PMID: 12125173
-
Vaccination of gnotobiotic primary specific pathogen-free pigs against Haemophilus parasuis.Can J Vet Res. 1991 Jan;55(1):33-6. Can J Vet Res. 1991. PMID: 1832078 Free PMC article.
-
Cross protection among Haemophilus parasuis strains in immunized gnotobiotic pigs.Can J Vet Res. 1991 Jan;55(1):37-41. Can J Vet Res. 1991. PMID: 1884282 Free PMC article.
-
Advances in the quest for virulence factors of Haemophilus parasuis.Vet J. 2013 Dec;198(3):571-6. doi: 10.1016/j.tvjl.2013.08.027. Epub 2013 Sep 4. Vet J. 2013. PMID: 24084037 Review.
-
Update on Glässer's disease: How to control the disease under restrictive use of antimicrobials.Vet Microbiol. 2020 Mar;242:108595. doi: 10.1016/j.vetmic.2020.108595. Epub 2020 Jan 25. Vet Microbiol. 2020. PMID: 32122599 Review.
Cited by
-
Molecular serotyping of clinical strains of Haemophilus (Glaesserella) parasuis brings new insights regarding Glässer's disease outbreaks in Brazil.PeerJ. 2019 May 23;7:e6817. doi: 10.7717/peerj.6817. eCollection 2019. PeerJ. 2019. PMID: 31198621 Free PMC article.
-
Evaluation of the recombinant proteins RlpB and VacJ as a vaccine for protection against Glaesserella parasuis in pigs.BMC Vet Res. 2020 May 27;16(1):167. doi: 10.1186/s12917-020-02377-5. BMC Vet Res. 2020. PMID: 32460764 Free PMC article.
-
Characterization and Vaccine Potential of Outer Membrane Vesicles Produced by Haemophilus parasuis.PLoS One. 2016 Mar 1;11(3):e0149132. doi: 10.1371/journal.pone.0149132. eCollection 2016. PLoS One. 2016. PMID: 26930282 Free PMC article.
-
Transcriptomic differences noted in Glaesserella parasuis between growth in broth and on agar.PLoS One. 2019 Aug 6;14(8):e0220365. doi: 10.1371/journal.pone.0220365. eCollection 2019. PLoS One. 2019. PMID: 31386681 Free PMC article.
-
Capsular immunity is necessary for protection against some but not all strains of Glaesserella parasuis.Vet Microbiol. 2025 Jun;305:110509. doi: 10.1016/j.vetmic.2025.110509. Epub 2025 Apr 11. Vet Microbiol. 2025. PMID: 40250105 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical